Can Aspirin Be Taken in Pregnancy with Placenta Lakes?
Yes, a pregnant woman with placenta lakes can and should take low-dose aspirin if she has risk factors for preeclampsia, as placenta lakes themselves are not a contraindication to aspirin therapy. 1, 2
Understanding Placenta Lakes and Aspirin Safety
Placenta lakes (also called placental lacunae or intervillous lakes) are blood-filled spaces within the placenta that appear on ultrasound. The critical evidence shows that:
- Low-dose aspirin does not increase the risk of placental abruption, postpartum hemorrhage, or fetal intracranial bleeding in pregnant women, including those with placental abnormalities 1, 2
- The presence of placenta lakes is not listed as a contraindication to aspirin therapy in any major guideline 1
- Aspirin actually improves uteroplacental blood flow and placentation, which may theoretically benefit women with placental vascular issues 3, 4
Determining If Aspirin Is Indicated
Aspirin should be prescribed if the patient has any high-risk factors for preeclampsia:
High-Risk Factors (any one warrants aspirin) 1, 2:
- History of preeclampsia (especially early-onset <34 weeks)
- Chronic hypertension
- Type 1 or type 2 diabetes
- Renal disease
- Autoimmune disease (SLE, antiphospholipid syndrome)
- Multifetal gestation
Multiple Moderate-Risk Factors (consider aspirin with several) 1, 2:
- Nulliparity
- Maternal age ≥35 years
- BMI >30 kg/m²
- Family history of preeclampsia
- Interpregnancy interval ≥10 years
Optimal Dosing and Timing
The most recent high-quality evidence supports higher doses than traditionally recommended:
Dose: 100-150 mg daily (not the older 81 mg recommendation) 1, 2
Timing: Start between 12-16 weeks of gestation (optimally before 16 weeks) 1, 2
Duration: Continue daily until delivery (do not stop at 36 weeks) 1, 2
Benefits of Aspirin Therapy
When prescribed appropriately, low-dose aspirin provides:
- 24% reduction in preeclampsia risk 1, 2
- 14% reduction in preterm birth 1
- 20% reduction in intrauterine growth restriction (IUGR) 1, 2
- Improved fetal weight in cases of placental insufficiency 6
Safety Profile
The safety evidence is robust and reassuring:
- No increased risk of placental abruption (even with placental abnormalities) 1, 2
- No increased risk of postpartum hemorrhage 1, 2
- No increased risk of fetal intracranial bleeding 1, 2
- No increased perinatal mortality 1, 2
- No increased risk of congenital anomalies when used at low doses 1, 7
Critical Caveats
Avoid aspirin only if:
- Patient has documented aspirin allergy or intolerance 1
- Active bleeding disorder is present 7
- Patient is taking anticoagulation therapy (requires specialist consultation) 1
Important distinction: The FDA warning about aspirin in pregnancy refers to high doses (>100 mg for analgesic purposes), not the prophylactic low doses (75-150 mg) used for preeclampsia prevention 2
Clinical Implementation
For your patient with placenta lakes:
- Assess preeclampsia risk factors using the criteria above 1, 2
- If any high-risk factor is present, prescribe aspirin 100-150 mg daily 1, 2
- Start between 12-16 weeks if not already initiated 1, 2
- Continue until delivery 1, 2
- Monitor placenta lakes per standard obstetric protocols, but do not discontinue aspirin based on their presence alone 1
The presence of placenta lakes should prompt careful obstetric monitoring but does not contraindicate aspirin therapy when otherwise indicated for preeclampsia prevention.